Peptides represent one of the fastest growing segments of the pharmaceutical industry. This can be attributed to the rapidly growing pipeline of peptide-based therapeutics, driven by the need for effective and personalized pharmacological interventions.
The global peptide synthesis market, valued at USD 3.8 billion in 2025, is projected to reach USD 4.2 billion in 2026 and USD 6.0...